title: Combination therapy/prophylaxis with interferon and ribavirin for recurrent hepatitis C after liver transplantation: long-term effects on graft function and morphology.
authors.affiliation: Department of General and Visceral Surgery, Friedrich-Schiller-University, Jena, Germany. Arno.Kornberg@med.uni-jena.de
authors.forename: A
authors.initials: A
authors.lastname: Kornberg
authors.forename: M
authors.initials: M
authors.lastname: Hommann
authors.forename: A
authors.initials: A
authors.lastname: Tannapfel
authors.forename: T
authors.initials: T
authors.lastname: Grube
authors.forename: U
authors.initials: U
authors.lastname: Schotte
authors.forename: J
authors.initials: J
authors.lastname: Scheele
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006526:Hepatitis C / Q000188:drug therapy* / Q000453:epidemiology* / Q000601:surgery; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use*; D007970:Leukopenia / Q000139:chemically induced; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D011994:Recombinant Proteins; D012008:Recurrence; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase